ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 148

Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis?

M. Anthony Albornoz1, Christian Albornoz2 and Daniel J. Clauw3, 1Rheumatology, Riddle Memorial Hospital/Mainline Health System, Media, PA, 2Temple University School of Medicine, Philadelphia, PA, 3Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Anxiety, depression and fibromyalgia, Sexuality

Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression is reported in as many as 71% of patients with Fibromyalgia (FM). An association between Childhood Sexual Abuse (CSA) and FM has been well documented and is responsible for inducing disturbing levels of chronic physical and psycho-affective morbidity. Based on the 28-year experience of the lead author, the frequency of CSA in patients with Fibromyalgia-Depression Overlap (FDO) is thought to be highly underestimated, principally due to the underutilization of validated screening questions by Rheumatologists (RH), Internists and Family Medicine Physicians (PCP). We primarily sought to determine the frequency of CSA screening by RH and PCP in patients with FDO and the incidence of CSA in new patients with FDO. Additional clinical and psychosocial variables were secondarily assessed.

Methods: A retrospective analysis conducted over a 12 month period in an outpatient, community-based, solo private practice setting of 131 consecutive new adult patients diagnosed with FM by one RH. All patients were screened for depression, anxiety and CSA using validated tools(PHQ-9, GAD-7,Gen Hosp Psychiatry. 2007 Jan-Feb;29(1):8-13) . CSA patients were asked whether past and/or present PCP and past RH inquired about CSA. All patients met the 2010 ACR criteria for FM.

Results: All data is summarized in Table. Noteworthy clinical findings included: Of the 131 FM patients, 100% were female, 82 (63%) were diagnosed with FDO and 18 (22%) of FDO patients revealed they were victims of CSA; CSA was not encountered in the non-FDO population; CSA mean age was 42 with an age range of 18-74; mean age at time of abuse 13; oldest age when CSA first divulged was 74; 16 (89%) of CSA patients were under age 65 and of these 13 (81%) were either on disability or unemployed; 6 (33%) family member(‘s) did not believe claim of CSA; 14 (78%) of CSA patients requested that abuse history not be included in the medical record; 11 (61%) of assailants were 1st degree relatives; CSA patients never queried by physicians about sexual abuse: active and/or past PCP 15 (83%) and past RH 9 (100 %); Psychiatric/Psychological care given in 18 (100%) of CSA patients; 18 (100%) of CSA patients experienced past suicidal ideations and 11 (61%) active suicidal ideations; 8 (44 %) attempted suicide; 18 (100%) had active depression and 16 (89%) had active anxiety; 15 (83%) active severe depression; 14 (78%) active severe anxiety; 16 (89%) active panic attacks.

Conclusion: The structure and small sample size of this investigation limits our ability to draw definitive conclusions. However, these data reveal that in an alarmingly high number of FDO patients previously evaluated by RH and PCP, CSA escaped detection. The results of this analysis highlights that patients with FDO-CSA likely represent a particularly at-risk population who are in need of greater physician awareness and a more focused assessment. A multi-state study addressing this topic is in progress.


Disclosure: M. A. Albornoz, None; C. Albornoz, None; D. J. Clauw, Abbott Pharmaceutical, 5,Aptinyx, 5,Astellas Phamaceutical, 5,Cerephex, 5,Daiichi Sankyo, 5,Pfizer Inc, 5,Pierre Fabre, 8,Samumed, 5,Theravance, 5,Tonix, 5.

To cite this abstract in AMA style:

Albornoz MA, Albornoz C, Clauw DJ. Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/lack-of-screening-by-rheumatologists-and-primary-care-physicians-for-childhood-sexual-abuse-in-patients-with-fibromyalgia-depression-overlap-an-unrecognized-crisis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lack-of-screening-by-rheumatologists-and-primary-care-physicians-for-childhood-sexual-abuse-in-patients-with-fibromyalgia-depression-overlap-an-unrecognized-crisis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology